| CVD19-425A-1 |
N SARS-CoV-2 Nucleocapsid mRNA (Transfection-ready)(System Biosciences)
|
|
N/A |
N/A |
| CVD19-420A-1 |
N SARS-CoV-2 Nucleocapsid mRNA (Transfection-ready)(System Biosciences)
|
|
N/A |
N/A |
| CVD19-260A-1 |
HEK293-ACE2-NRP1 Overexpression Stable Cell Line(System Biosciences)
|
|
N/A |
N/A |
| CVD19-220A-1 |
HEK293 ''N SARS-CoV-2 Nucleocapsid Overexpression Stable Cell Line(System Biosciences)
|
|
N/A |
N/A |
| CVD19-200A-1 |
HEK293 ACE2 Stable Cell Line(System Biosciences)
|
|
N/A |
N/A |
| CVD19-140VA-1 |
NRP1 Expression Lentivector, pCDH-CMV-NRP1-EF1alpha-Neo (Pre-packaged Lentivirus)(System Biosciences)
|
|
N/A |
N/A |
| CVD19-140PA-1 |
NRP1 Expression Lentivector, pCDH-CMV-NRP1-EF1alpha-Neo (Plasmid)(System Biosciences)
|
|
N/A |
N/A |
| CVD19-135VA-1 |
SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-hS-EF1alpha-Puro (Pre-packaged Lentivirus)(System Biosciences)
|
|
N/A |
N/A |
| CVD19-135PA-1 |
SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-hS-EF1alpha-Puro (Plasmid)(System Biosciences)
|
|
N/A |
N/A |
| CVD19-130VA-1 |
SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-S-EF1alpha-Puro (Pre-packaged Lentivirus)(System Biosciences)
|
|
N/A |
N/A |
